Swedbank fined $50 million by New York authorities over Panama Papers revelations 
How offshore firms helped a mafia-linked Italian druglord hide a $230m fortune 
The Subcontinent’s Philosophical Rupture 
By: Tomoaki Takei
Multinational pharma giant Eli Lilly’s Mounjaro (tirzepatide), the dual GIP/GLP-1 receptor agonist, is at the center of a rapidly escalating public health storm in East Asia. While clinically approved as a life-saving treatment for Type 2 diabetes, the drug has been effectively deified on social media as the ultimate cosmetic weight-los…
Don't Miss:
-
Swedbank fined $50 million by New York authorities over Panama Papers revelations
-
How offshore firms helped a mafia-linked Italian druglord hide a $230m fortune
-
The Subcontinent’s Philosophical Rupture
-
Can Small Modular Reactors Make Nuclear Work in Southeast Asia
-
West Virginia State Senate Race Comes Down to Two Words — Data Centers